Establishment of a human glioblastoma rabbit brain model: Testing the therapeutic effect of stem cells delivered via selective intra-arterial infusion
Abstract：Glioblastoma (GBM) is the most common and most malignant primary brain tumor in adults, with a median survival of only 14.6 months with current therapies [1]. Traditional intravenous drug administration is limited by the difficulty of drugs penetrating the blood-brain barrier and low systemic distribution efficiency [2-3].
Machine-generated Keywords：
Publication Date：2025-07-20
Online Publishing Date：2025-08-21(First online date of this platform, not the publication date of the document)
Pages：1( 442 )